Wound Packing with Multi-Potent Cells and Collagen

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for chronic wounds, such as those experienced by individuals with diabetes or poor blood flow, are often ineffective or slow, leading to prolonged recovery times and potential amputation, highlighting the need for improved wound healing methods.

Innovation Solution

A wound packing system comprising multi-potent cells, plasma, and collagen, optionally with skin seeds and a protective barrier, is applied to the wound to promote healing, where the components are combined and shaped to fit the wound, and thickened with agents like thrombin to form a cohesive packing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments and bandages are used for chronic wounds, then the wound may eventually heal, but the healing process is relatively slow and treatment time is extended

Engineering Contradiction:
Improvewound healing effectivenessVSAvoidtreatment and recovery time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The wound packing is prepared in advance with multi-potent cells, plasma, and collagen components pre-combined and activated before application to the wound. This preliminary preparation ensures that regenerative factors are immediately available upon contact with the wound bed, eliminating the need for gradual introduction of healing agents and significantly accelerating the initial healing phase.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention combines multiple biologically active components (multi-potent cells, plasma, collagen, and thickening agents) into a single composite wound packing material. This composite structure provides synergistic effects where each component contributes different functions: cells provide regenerative capacity, plasma provides growth factors, collagen provides structural framework, and thickening agents provide gel formation. This multi-component composite accelerates healing beyond what single conventional treatments can achieve.

Inventive Principle:
Principle #40Composite materials

2Reliability

If conventional wound treatments are applied, then the wound may close over time, but the process is prolonged and may require extensive medical intervention

Engineering Contradiction:
Improvewound closure achievementVSAvoidhealing rate
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The wound packing is designed to be self-sustaining and self-regulating. The multi-potent cells within the packing continuously differentiate and regenerate tissue without requiring external intervention. The plasma and collagen matrix provide a self-contained environment that maintains moisture and delivers growth factors autonomously. This self-service capability ensures consistent healing progression without frequent medical visits or adjustments, significantly improving healing productivity.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The invention fundamentally changes the biochemical parameters of the wound environment by introducing activated plasma and growth factors that alter the healing kinetics. The thickening agents transform the physical state from liquid to gel, creating optimal conditions for cell proliferation. These parameter changes accelerate the healing rate from weeks/months to days/weeks, directly improving productivity while maintaining reliable wound closure.

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If simple bandages and ointments are used, then the treatment is easy to apply, but the effectiveness at treating chronic wounds is relatively low

Engineering Contradiction:
Improveapplication simplicityVSAvoidchronic wound treatment effectiveness
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The wound packing system is segmented into modular components that can be prepared separately and then assembled: multi-potent cells, plasma, collagen, and thickening agents can be prepared in separate vials or compartments and then combined directly at the wound site. This segmentation maintains ease of application while incorporating advanced therapeutic components that significantly improve chronic wound treatment effectiveness compared to simple monolithic bandages.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The collagen and plasma matrix serve as intermediaries that bridge the gap between simple application and complex therapy. These materials provide a carrier medium that delivers multi-potent cells and growth factors to the wound bed in a controlled manner. The intermediary matrix simplifies the application process (similar to applying an ointment) while simultaneously providing the complex biochemical environment needed for effective chronic wound healing.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The wound packing system accelerates wound closure and healing by utilizing the regenerative properties of multi-potent cells and plasma, potentially reducing recovery time and the risk of complications like amputation.

Implementation Method 1

thrombin, calcium chloride, one or more serine proteases, and/or any other suitable thickening agent or agents are combined with the multi-potent cells, plasma, and/or collagen to coagulate, gel, and/or otherwise harden the components to form a wound packing

Methodology Applied
Scientific EffectCoagulation: Coagulation

Implementation Method 2

thrombin, calcium chloride, one or more serine proteases, and/or any other suitable thickening agent or agents are combined with the multi-potent cells, plasma, and/or collagen to coagulate, gel, and/or otherwise harden the components

Methodology Applied
Scientific EffectThickening: Shear Thickening

Data Source

PatentUS20200390930A1Systems and methods for treating a wound with wound packing
Publication Date: 2020.12.17 SCION SOLUTIONS LLC
  • US20200390930A1 patent drawing
  • US20200390930A1 patent drawing
  • US20200390930A1 patent drawing

AI summary

Methods for treating a wound with a wound packing are discussed. While the wound packing can include any suitable component, in some cases, it includes a collection of multi-potent cells (e.g., cells from bone marrow, amniotic membrane tissue, amniotic fluid, stem cells, etc.), plasma (e.g., concentrated and/or platelet rich plasma), and collagen (e.g., native and/or organized reconstituted collagen). In some cases, the wound packing is gelled, coagulated, or otherwise hardened through the use of thrombin, calcium chloride, and/or another suitable additive. In some cases, the wound packing is shaped to substantially correspond to the wound's shape. While the wound packing can be used in any suitable manner, in some instances, it is applied to the wound, skin fragments are applied to the packing, the packing is secured to the wound, and/or the packing is covered with a protective barrier. Other implementations are also described.